Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/10/837
Active ingredient: Plitidepsin
Indication: Treatment of primary myelofibrosis
Sponsor: Pharma Mar S.A.
Avda de los Reyes 1, Polígono Industrial La Mina, E-28770 Colmenar Viejo, Madrid, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/03/2011 Orphan designation EMA/OD/123/10 (2011)1303 of 23/02/2011
27/06/2011 Removal of orphan designation from Community Register